Ashish M. Kamat, MD, MBBS, FACS, Department of Urology, Division of Surgery
This study will evaluate the safety and efficacy of intravesical administration of EG-70 in the bladder and its effect on bladder tumors in patients with NMIBC. This study study consists of two phases; a Phase 1 dose-escalation to establish safety and recommended the phase 2 dose, followed by a Phase 2 study to establish how effective the treatment is. The Study will include patients with NMIBC with Cis for whom BCG therapy is unresponsive and patients with NMIBC with Cis who are BCG-naïve or inadequately treated.
This study will test a drug called enfortumab vedotin in participants with a type of bladder cancer called non-muscle invasive bladder cancer (NMIBC). This study will also evaluate what the side effects are and if the drug works to treat NMIBC. A side effect is anything a drug does to your body besides treating your disease. In this study enfortumab vedotin will be put into the bladder using a catheter. A catheter is a thin tube that can be put into your bladder.
This randomized phase III trial studies Tokyo-172 strain bacillus Calmette-Guerin (BCG) solution with or without a vaccination using Tokyo-172 strain BCG to see how well it works compared with TICE BCG solution in treating patients with bladder cancer that has not spread to muscle. BCG is a non-infectious bacteria that when instilled into the bladder may stimulate the immune system to fight bladder cancer. Giving different versions of BCG with vaccine therapy may prevent bladder cancer from returning.
An unusual diagnosis of a brain tumor in the bladder was no match for the treatment planned by MD Anderson’s experts – or for University of Oklahoma soccer player Jazzy Richards.
Bladder cancer survivor Margo Wickersham came to MD Anderson for a special diagnostic procedure offered by very few hospitals. What she received here was a corrected diagnosis — and exemplary care that likely saved her life.
When Andre Stenzel was diagnosed with bladder cancer, his daughter, Maja Latham, took it upon herself to find the best bladder cancer treatment for her dad. Now she's speaking out to raise awareness about bladder cancer.
Karen Duddlesten loved every minute she spent with her husband during his bladder cancer journey. Today, she keeps his memory alive by leading the non-profit he founded to help the less fortunate.